MBBS, FACEM, FCICM, PhD
Matt is a senior consultant in Intensive Care Medicine and Emergency Medicine who has worked in Geelong for over 10 years. He has provided a VMO service at St John of God Hospital, consults at the Geelong Hospital Emergency Department and maintains a research program at the Royal Adelaide Hospital ICU.
Matt has a particular interest in pre-clinical research and has completed a PhD thesis describing the thyroid hormone changes in critical illness. Otherwise it is music, horses, Essendon Football Club or running around 5 children that occupies his time.
Head of Research
Matt has a particular interest in pre-clinical research and has completed a PhD thesis describing the thyroid hormone changes in critical illness. Otherwise it is music, horses, Essendon Football Club or running around 5 children that occupies his time.
Latest news:
-
Thursday, April 8, 2021 - 16:13
JAMA BACLOREA High-dose baclofen reduced agitation-related events in adult patients with unhealthy alcohol use requiring mechanical ventilation. However secondary outcomes of deeper sedation, longer duration of mechanical ventilation, prolonged ICU care = more research
Tuesday, April 6, 2021 - 14:25JAMA Mechanical ventilation weaning practices vary internationally, regard to the use of protocols, screening for and conducting SBTs, adjustment of ventilator support, and the responsibility of clinicians involved in weaning
Tuesday, April 6, 2021 - 12:01JAMA HENIVOT Trial -Helmet NIV vs HFNC for critically ill patients with mod-severe hypoxemic COVID resp failure = no diff in the resp support fee days (28 d). Secondary diff in intubation, lower in helmet group, ie overall no difference in 28-d resp support, but helmet lower proportion of this time intubated.
Friday, February 19, 2021 - 07:30JAMA RCT does not support use of single high dose oral vitamin D3 for treatment of moderate to severe COVID-19 in hospitalized patients. Limitations in design, however, confirms lack of benefit reported in multiple large non-COVID trials in hospital or ICU patients (VIOLET, VITdAL-ICU)
Sunday, February 14, 2021 - 09:30NEJM DePPaRT: 1% of patients with loss of cardiac activity after planned withdrawal of life sustaining therapy have transient resumption of cardiac activity observable by bedside reports and corroborated by ECG and IABP waveform activity. Retrospective waveform review showed resumption of cardiac activity in 14% of patients. The longest period of pulselessness that was followed by resumption of cardiac activity was 4 minutes 20 seconds.